COMMUNIQUÉS West-GlobeNewswire

Remedy’s Nutrition® Unveils Hair Tissue Mineral Analysis: A Revolutionary Personalized Approach to Nutritional Wellness
09/01/2026
KEY LARGO, Fla., Jan. 09, 2026 (GLOBE NEWSWIRE) -- Remedy's Nutrition® , a pioneering natural health company established in 1972, today announced the launch of its cutting-edge diagnostic service: Hair Tissue Mineral [...]
Dogecoin Cash, Inc. Becomes Among the First U.S. Public Companies to Complete a FINRA‑Notified Blockchain‑Linked Security Distribution
09/01/2026
FINRA Daily List Confirms “ Dividend Payable in Another Security” for DOGP MESQUITE, NV, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Mesquite, NV January 9, 2026 — Dogecoin Cash, Inc. (OTC: DOGP) today announced that the [...]
Sanuwave Health Announces Preliminary Q4 2025 Revenue of $13.3–$13.4 Million, Up 29–30% Year-over-Year; Achieves Record Quarterly and Full-Year Revenue
09/01/2026
Sanuwave is pleased to announce preliminary revenues of $13.3 million to $13.4 million for the fourth quarter ended December 31, 2025. This represents the highest quarterly revenues in Company history. Q4 2025 revenue [...]
RadNet, Inc. to Present at the 44th Annual J.P. Morgan Healthcare Conference January 14th, 2026
09/01/2026
LOS ANGELES, Jan. 09, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated [...]
Athira Pharma Announces Name Change to LeonaBio, Inc. with New Ticker “LONA”
09/01/2026
New name to reflect recent transformative acquisition of rights to Phase 3 program in metastatic breast cancer and commitment to continued leadership, resilience and innovation BOTHELL, Wash., Jan. 09, 2026 (GLOBE [...]
Avance Clinical to Showcase New Early Phase Center of Excellence at Biotech Showcase 2026
09/01/2026
ADELAIDE, Australia, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Avance Clinical, the award-winning Australian led, global CRO built exclusively to service the clinical research needs of biotech companies, announced today that [...]
Tiziana Life Sciences to Present at the 9th Annual Neuroscience Innovation Forum During J.P. Morgan Healthcare Conference Week in San Francisco
09/01/2026
BOSTON, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA ) (“Tiziana”), a biotechnology company developing its lead candidate, intranasal foralumab, a fully human, anti-CD3 monoclonal antibody [...]
Immunocore announces 2026 strategic priorities at 44th Annual J.P. Morgan Healthcare Conference
09/01/2026
Immunocore announces 2026 strategic priorities at 44 th Annual J.P. Morgan Healthcare Conference Reaching more metastatic uveal melanoma patients with KIMMTRAK (tebentafusp) in 2026 through US community and global [...]
Memo Therapeutics AG Publishes BKPyV Infection Disease Burden Study in the Journal of Patient-Reported Outcomes
09/01/2026
PRESS RELEASE Memo Therapeutics AG Publishes BKPyV Infection Disease Burden Study in the Journal of Patient-Reported Outcomes First conceptual model demonstrating the impact of BK polyomavirus on the health-related [...]
Amarin Applauds Breakthroughs In Therapies For Patients With Elevated Triglycerides; Company’s VASCEPA®/VAZKEPA® (Icosapent Ethyl) Franchise Well Positioned To Benefit Globally From Broadened Category Commercialization
09/01/2026
DUBLIN and BRIDGEWATER, N.J., Jan. 09, 2026 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN), a company advancing the science of cardiovascular therapeutics worldwide, today commented on recent innovations in [...]
Aquestive Therapeutics Announces Regulatory Development for Anaphylm™ (dibutepinephrine) Sublingual Film and Provides Business Update
09/01/2026
Announces receipt of FDA letter stating it has identified deficiencies that preclude labeling discussions for Anaphylm at this time Receives confirmation from FDA that Agency’s review of Anaphylm NDA application is [...]
MapLight Therapeutics Updates Expected Timing of Topline Results for Ongoing Phase 2 Studies to Q3 2026
09/01/2026
SAN FRANCISCO and BOSTON, Jan. 09, 2026 (GLOBE NEWSWIRE) -- MapLight Therapeutics, Inc. (MapLight) (Nasdaq: MPLT) today announced an update to the expected timing of topline results for its ongoing Phase 2 ZEPHYR and [...]
Ocugen CEO to Present at J.P. Morgan 2026 Healthcare Conference
09/01/2026
MALVERN, Pa., Jan. 09, 2026 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that Dr. Shankar Musunuri [...]
Zealand Pharma enters agreement with DCAI to use Gefion AI supercomputer to accelerate drug discovery and support Metabolic Frontier 2030 strategy
09/01/2026
Press release – No. 2 / 2026 Zealand Pharma enters agreement with DCAI to use Gefion AI supercomputer to accelerate drug discovery and support Metabolic Frontier 2030 strategy Access to Gefion, Denmark’s flagship AI [...]
Allegro to start production of osteoarthritis hydrogel as it prepares for clinical trials
09/01/2026
Wallonia Minister of Economy and Employment Pierre-Yves Jeholet will perform opening ceremony on 9 January 2026 New cleanroom facility allows production of one million doses per year Ramping up for clinical development [...]
O3R-5671 Pharmacokinetic and Pharmacodynamic Data to be Presented at ECCO and Dosing in Final Cohort in First-in-human study initiated
09/01/2026
Data from the first in human study on O3R-5671’s potent TNFα inhibition to be presented Dosing of the final cohort in the first in human study has been initiated Studies in ulcerative colitis and psoriasis to initiate [...]
Now Available: 1G Live Resin THCA Disposable By The Hemp Doctor
09/01/2026
MOORESVILLE, N.C., Jan. 09, 2026 (GLOBE NEWSWIRE) -- Trusted by customers for high-quality hemp-derived THC products and vapes since 2018, The Hemp Doctor launches its newest innovation: the ZOOTED | THCA Live Resin 1G [...]
Monte Rosa Therapeutics Announces Pricing of $300 Million Underwritten Public Offering
09/01/2026
BOSTON, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Monte Rosa Therapeutics, Inc . (“Monte Rosa”) (Nasdaq: GLUE), a clinical-stage biotechnology company developing novel molecular glue degrader (MGD)-based medicines, today [...]
Tecan reports return to sales growth and strong order entry in the second half of 2025
09/01/2026
Ad hoc announcement pursuant to Article 53 of the SIX Exchange Regulation Listing Rules Tecan reports return to sales growth and strong order entry in the second half of 2025 Group sales of CHF 882.5 million, down 1.6% [...]

Pages